GW Pharmaceuticals Is The Most Legit Among Marijuana Stocks

GW Pharmaceuticals or GWPH stock has exploded in the last year, up about eight-fold from spring 2013. But unfortunately, its valuation is based more on hope than anything since the company continues to operate in the red as it hopes for results to materialize from its drug pipeline. It’s one and only product, the marijuana-based... more →
Posted in: News

Marijuana Stocks To Watch Out For, According To NASDAQ

Thanks to Sativex, it has a solid revenue stream, generating over $46 million in the last 12 months. The company’s cash position also looks pretty good, with $234 million in cash and cash equivalents. 2. Insys Therapeutics Insys Therapeutics’ financial position looks even better than GW Pharmaceuticals, but not from any... more →
Posted in: Investing

3 Marijuana Stocks To Watch, According to NASDAQ

Unfortunately, some could be headed for such a disaster with marijuana stocks. With several states fully legalizing cannabis and others allowing medicinal use of the drug, money has poured into companies that seem poised to profit from the nascent market. The problem is that investors could very well see their dollars go up in smoke... more →
Posted in: Investing

This Is a Big Win for Marijuana and Researchers

Over the past decade, the legal wins enjoyed by marijuana and its supporters have far outnumbered the losses. Despite Florida failing to become the 24th state to legalize medical marijuana in last year’s election (by a mere two percentage points), we’ve still seen a rapid rise in the number of new states willing to give... more →
Posted in: Investing

Is Marijuana Stocks The Best Stocks To Invest In Nowadays?

If so, much of the debate would center on the medical benefits of marijuana in key indications such as cancer pain, diabetes, mental health, and epilepsy. As such, investors hoping to benefit from medical marijuana are focusing on drug companies that seek to profit from developing marijuana-derived medicines.The two drugmakers that... more →
Posted in: Investing

Risks Of Investing In Medical Marijuana Exposed By GW Pharmaceuticals

Unfortunately for the two companies, Sativex did not show it was statistically better at managing pain than a sugar pill placebo. The companies evaluated Sativex’s performance on two different scales, and the drug failed to hit its target on both. In addition, 19% of patients withdrew from treatment because of adverse events... more →
Posted in: Investing

There Are Risks Of Investing In Medical Marijuana, Says GW Pharmaceuticals

This trial studied the effectiveness of Sativex use alongside opioid therapy in controlling pain in 399 patients. Unfortunately for the two companies, Sativex did not show it was statistically better at managing pain than a sugar pill placebo. The companies evaluated Sativex’s performance on two different scales, and the drug... more →
Posted in: Investing

Bad News For The Legal Marijuana Movement

Data from GW Pharmaceuticals in its early stage studies has looked promising, and further underlines the potential of cannabinoids for medical purposes. Uncertainty surrounding marijuana’s long-term usage could stymie the sales potential of cannabinoid-based drugs like those being developed by GW Pharmaceuticals, and could... more →
Posted in: Investing
1 2